CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013		Jun. 30, 2012
Revenues
Internet marketing revenues	$ 1,580,984	$ 2,389,725	$ 3,083,263		$ 4,509,233
Net revenues from nutraceutical sales	4,604,091		6,860,936
Merchandise sales, net	6,091,367		6,091,367
Placement fees	1,691,636		1,691,636
Gift cards and other	2,563,663		2,563,663
Total revenues	16,531,741	2,389,725	20,290,865		4,509,233
Cost of revenues	11,595,440	1,455,511	14,221,789		2,835,336
Gross profit	4,936,301	934,214	6,069,076		1,673,897
Operating expenses:
Catalog expenses	759,363		759,363
Sales and marketing	2,202,738	234,783	2,711,491		488,261
Customer service and fulfillment	314,241		314,241
General and administrative	5,612,510	923,539	6,960,049		1,494,417
Research and development	357,242	102,499	628,808		189,825
Total operating expenses	9,246,094	1,260,821	11,373,952		2,172,503
Loss from operations	(4,309,793)	(326,607)	(5,304,876)		(498,606)
Other income (expense):
Interest expense	(32,901)	(15,107)	(41,096)		(19,668)
Other income	4,781		4,781
Loss on debt conversion			(66,431)
Net loss	$ (5,407,622)	$ (518,274)	$ (5,407,622)	[1]	$ (518,274)
Net loss per common share Basic and Diluted	$ (0.05)	$ (0.01)	$ (0.07)		$ (0.01)
Weighted-average common shares used to calculate net income per common share: Basic and diluted	90,608,624	66,583,676	79,456,896		66,583,676

[1] Restated